| Filed On | Filing |
|---|---|
| 10 Sep 2026 |
Form 3: Zamir Haggai, Director
No securities owned |
| 01 Sep 2026 |
Form 3: Hexter Joshua, Interim CEO
No securities owned |
| 28 Aug 2026 |
Form 3: Greenwald Yonason, Director
No securities owned |
| 24 Aug 2026 |
Form 3: Gabay Avraham, Director
No securities owned |
| 20 May 2026 |
Form 3: Rose Keith Dale, Chief Medical Officer
Holds 2,083 shares of Ordinary Shares, no par value per share |
| 14 May 2026 |
Form 3: Oramed Pharmaceuticals Inc., 10% owner
Holds 1,250,363 shares of Ordinary Shares |
| 13 Apr 2026 |
Form 3: Sigsbee William Mark, Director
No securities owned |
| 13 Apr 2026 |
Form 3: Rozenbaum Moshe H, Director
No securities owned |
| 27 Mar 2026 |
Form 3: Reznick Yehuda, Director
No securities owned |
| 27 Mar 2026 |
Form 3: Kidron Nadav, Director
No securities owned |
| 27 Mar 2026 |
Form 3: Kidron Miriam, Director
No securities owned |
| 04 Jun 2025 |
Form 3: Grant William Mark, President & Co-CEO
No securities owned |
| 07 Nov 2024 |
Form 3: Marshall Robert J. Jr., Director
No securities owned |
| 22 Apr 2024 |
Form 3: Swinford Michael, Director
No securities owned |
| 14 Aug 2023 |
Form 3: Remsberg Charles, Chief Sales Officer
No securities owned |
| 19 Sep 2022 |
Form 3: Lawless Michael A, Chief Financial Officer
No securities owned |
| 24 Aug 2022 |
Form 3: Levy Hadar, Director
No securities owned |
| 21 Apr 2022 |
Form 3: Turk Joseph E Jr, Director
No securities owned |
| 25 Mar 2022 |
Form 3: Adar Almog, Director of Finance
Holds 37,500 shares of Ordinary Shares |
| 27 Jan 2022 |
Form 3: Lind Global Fund Ii Lp, 10% owner and 1 other
Holds 2,932,218 shares of Ordinary Shares, par value NIS 0.25 per share |
Loading...
